Teleflex wins FDA nod for next-gen peripheral snares, launches in US
Teleflex (NYSE:TFX) said today it won FDA 510(k) clearance for its Expro Elite and Sympro Elite peripheral interventional snares and that it launched the devices in the US. Both newly cleared snares are next-generation versions of 0.035″ interventional snares launched in the US in 2008 by Vascular Solutions, which is now a wholly-owned subsidiary of Teleflex. The Expro Elite snare is designed to use a helical loop for all-direction capturing, and the Sympro Elite snare is designed to use a 90-degree loop which remains coaxial to the vessel, the Wayne, Penn.-based company said. Both devices are designed for use in the cardiovascular system and hollow viscus to retrieve or manipulate objects using minimally invasive surgical procedures. “We are excited to introduce to the market our enhanced versions of the Expro Elite and Sympro Elite Interventional Snares, which build on nearly a decade of reliable performance in the cath lab. Both devices feature greatly enhanced pull force for superior handling in challenging procedures. Both snare products feature a durable nitinol construction that retains its shape and adds strength, a radiopaque gold-plated tungsten coil and tip for enhanced visibility, 1:1 torque response for controlled positioning and better access to distal targets, and a unique locking handle that facilitates secure capture,” prez &interventional division GM Stewart Strong said in a press release. Last December, Teleflex said it inked...
Authors: Shemer A, Talmi L, Shouval DS, Har-Zahav G, Somech R PMID: 30109801 [PubMed - in process]
Authors: Mumcuoglu KY, Leibovici V, Reuveni I, Bonne O Abstract BACKGROUND: Delusional parasitosis (DP) is a somatic type of delusional disorder, usually mono-symptomatic, in which the patients are convinced they are being infested with animal parasites while no objective evidence exists to support this belief. The complaints are usually about skin infestation, but involvement of the gastrointestinal tract has also been described. Numerous samples are brought for examination from skin, clothes, and environmental sources, while a detailed description of the "parasite" is given. In primary DP, the delusion ...
Authors: Mannheim D, Karmeli R PMID: 30109799 [PubMed - in process]
Authors: Cavari Y, Ginzburg V, Szendro G, Leytzin A, Novik Farkash E, Lazar I PMID: 30109798 [PubMed - in process]
Authors: Chera HH, Cohen M, Ishakis R, Rosen Y, Ozeri DJ PMID: 30109797 [PubMed - in process]
Authors: Korytny A, Kibari A, Rosner I, Zisman D PMID: 30109796 [PubMed - in process]
CONCLUSIONS: As described by French, osteotomy has the ability to correct the varus deformity only in the coronal plane. However, our research supports the assumption that hyperextension in the sagittal plane might be corrected spontaneously. PMID: 30109795 [PubMed - in process]
Authors: Gentileschi S, Vitale A, Rigante D, Lopalco G, Emmi G, Orlando I, Di Scala G, Sota J, Fabiani C, Frediani B, Galeazzi M, Lapadula G, Iannone F, Cantarini L Abstract BACKGROUND: Clinical research is needed to identify patients with axial spondyloarthritis (axSpA) who are more likely to be responsive to interleukin (IL)-17 inhibition. OBJECTIVES: To evaluate short-term efficacy of secukinumab in the management of axSpA. METHODS: Twenty-one patients (7 males, 14 females) with axSpA were consecutively treated with secukinumab. Laboratory and clinical assessments were based on erythrocyte sedimentation ...
CONCLUSIONS: Ten years of data on BCs, focusing on six PCPs, demonstrates a significant, yet insufficient reduction in the rate of contamination. High creatinine level, isolation of Streptococcus viridans, and multiple positive BCs were predictors of TrueB, while growth of CoNS was strongly predictive of contamination. This model could assist in diagnostic and therapeutic decision making. PMID: 30109793 [PubMed - in process]
CONCLUSIONS: Dental appliances may be considered an appropriate second-choice option to treat severe OSA in patients who are noncompliant with CPAP. This study helps physicians identify patients with extremely severe OSA who are suitable for dental appliance treatment. Well-designed large-scale studies are needed to reach definitive conclusions. PMID: 30109792 [PubMed - in process]